Dataset Information


Rediscovering the wound hematoma as a site of hemostasis during major arterial hemorrhage.

ABSTRACT: BACKGROUND:Treatments for major internal bleeding after injury include permissive hypotension to decrease the rate of blood loss, intravenous infusion of plasma or clotting factors to improve clot formation, and rapid surgical hemostasis or arterial embolization to control bleeding vessels. Yet, little is known regarding major internal arterial hemostasis, or how these commonly used treatments might influence hemostasis. OBJECTIVES:(i) To use a swine model of femoral artery bleeding to understand the perivascular hemostatic response to contained arterial hemorrhage. (ii) To directly confirm the association between hemodynamics and bleeding velocity. (iii) To observe the feasibility of delivering an activated clotting factor directly to internal sites of bleeding using a simplified angiographic approach. METHODS:Ultrasound was used to measure bleeding velocity and in vivo clot formation by elastography in a swine model of contained femoral artery bleeding with fluid resuscitation. A swine model of internal pelvic and axillary artery hemorrhage was also used to demonstrate the feasibility of local delivery of an activated clotting factor. RESULTS:In this model, clots formed slowly within the peri-wound hematoma, but eventually contained the bleeding. Central hemodynamics correlated positively with bleeding velocity. Infusion of recombinant human activated factor VII into the injured artery near the site of major internal hemorrhage in the pelvis and axillae was feasible. CONCLUSIONS:We rediscovered that clot formation within the peri-wound hematoma is an integral component of hemostasis and a feasible target for the treatment of major internal bleeding using activated clotting factors delivered using a simplified angiographic approach.


PROVIDER: S-EPMC4777306 | BioStudies | 2015-01-01

REPOSITORIES: biostudies

Similar Datasets

2015-01-01 | S-EPMC4470483 | BioStudies
1000-01-01 | S-EPMC3031396 | BioStudies
2020-01-01 | S-EPMC7678143 | BioStudies
2017-01-01 | S-EPMC5612665 | BioStudies
2017-01-01 | S-EPMC5542647 | BioStudies
1000-01-01 | S-EPMC5924502 | BioStudies
2016-01-01 | S-EPMC4980575 | BioStudies
2011-01-01 | S-EPMC4157830 | BioStudies
2015-01-01 | S-EPMC4344417 | BioStudies
2019-01-01 | S-EPMC6895059 | BioStudies